352 related articles for article (PubMed ID: 26407762)
21. Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer.
Prieto-Potin I; Montagut C; Bellosillo B; Evans M; Smith M; Melchior L; Reiltin W; Bennett M; Pennati V; Castiglione F; Bürrig KF; Cooper U; Dockhorn-Dworniczak B; Rossenbach C; Luna-Aguirre CM; Barrera-Saldaña HA; Machado JC; Costa JL; Yacobi R; Tabibian-Keissar H; Buglioni S; Ronchetti L; Douglas-Berger L; Dubbink HJ; Alorini M; Sabourin JC; Rojo F
J Mol Diagn; 2018 Sep; 20(5):664-676. PubMed ID: 29959022
[TBL] [Abstract][Full Text] [Related]
22. Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples.
Weyn C; Van Raemdonck S; Dendooven R; Maes V; Zwaenepoel K; Lambin S; Pauwels P
BMC Cancer; 2017 Feb; 17(1):139. PubMed ID: 28201998
[TBL] [Abstract][Full Text] [Related]
23. BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay.
Tatsuno M; Shioda Y; Iwafuchi H; Yamazaki S; Iijima K; Takahashi C; Ono H; Uchida K; Okamura O; Matubayashi M; Okuyama T; Matsumoto K; Yoshioka T; Nakazawa A
Diagn Pathol; 2016 Apr; 11():39. PubMed ID: 27094161
[TBL] [Abstract][Full Text] [Related]
24. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
Evrard SM; Taranchon-Clermont E; Rouquette I; Murray S; Dintner S; Nam-Apostolopoulos YC; Bellosillo B; Varela-Rodriguez M; Nadal E; Wiedorn KH; Melchior L; Andrew E; Jones M; Ridgway J; Frykman C; Lind L; Rot M; Kern I; Speel EJM; Roemen GMJM; Trincheri N; Freiberger SN; Rechsteiner M
J Mol Diagn; 2019 Nov; 21(6):1010-1024. PubMed ID: 31445213
[TBL] [Abstract][Full Text] [Related]
25. Rapid clinical mutational testing of
Van Haele M; Vander Borght S; Ceulemans A; Wieërs M; Metsu S; Sagaert X; Weynand B
J Clin Pathol; 2020 Jan; 73(1):35-41. PubMed ID: 31296605
[TBL] [Abstract][Full Text] [Related]
26. Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays.
Fisher KE; Cohen C; Siddiqui MT; Palma JF; Lipford EH; Longshore JW
Hum Pathol; 2014 Nov; 45(11):2281-93. PubMed ID: 25228337
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
Long GV; Wilmott JS; Capper D; Preusser M; Zhang YE; Thompson JF; Kefford RF; von Deimling A; Scolyer RA
Am J Surg Pathol; 2013 Jan; 37(1):61-5. PubMed ID: 23026937
[TBL] [Abstract][Full Text] [Related]
28. Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
Solassol J; Vendrell J; Märkl B; Haas C; Bellosillo B; Montagut C; Smith M; O'Sullivan B; D'Haene N; Le Mercier M; Grauslund M; Melchior LC; Burt E; Cotter F; Stieber D; Schmitt FL; Motta V; Lauricella C; Colling R; Soilleux E; Fassan M; Mescoli C; Collin C; Pagès JC; Sillekens P
PLoS One; 2016; 11(9):e0163444. PubMed ID: 27685259
[TBL] [Abstract][Full Text] [Related]
29. Comparison between two widely used laboratory methods in BRAF V600 mutation detection in a large cohort of clinical samples of cutaneous melanoma metastases to the lymph nodes.
Jurkowska M; Gos A; Ptaszyński K; Michej W; Tysarowski A; Zub R; Siedlecki JA; Rutkowski P
Int J Clin Exp Pathol; 2015; 8(7):8487-93. PubMed ID: 26339422
[TBL] [Abstract][Full Text] [Related]
30. Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600).
Skorokhod A; Helmbold P; Brors B; Schirmacher P; Enk A; Penzel R
PLoS One; 2013; 8(3):e59221. PubMed ID: 23555633
[TBL] [Abstract][Full Text] [Related]
31. Detection of BRAF V600E Mutation in Ganglioglioma and Pilocytic Astrocytoma by Immunohistochemistry and Real-Time PCR-Based Idylla Test.
Durślewicz J; Klimaszewska-Wiśniewska A; Antosik P; Kasperska A; Grzanka D; Szylberg T; Szylberg Ł
Dis Markers; 2020; 2020():8880548. PubMed ID: 32879641
[TBL] [Abstract][Full Text] [Related]
32. Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies.
Lamy PJ; Castan F; Lozano N; Montélion C; Audran P; Bibeau F; Roques S; Montels F; Laberenne AC
J Mol Diagn; 2015 Jul; 17(4):366-73. PubMed ID: 25952101
[TBL] [Abstract][Full Text] [Related]
33. Assessment of a fully automated high-throughput DNA extraction method from formalin-fixed, paraffin-embedded tissue for KRAS, and BRAF somatic mutation analysis.
van Eijk R; Stevens L; Morreau H; van Wezel T
Exp Mol Pathol; 2013 Feb; 94(1):121-5. PubMed ID: 22750048
[TBL] [Abstract][Full Text] [Related]
34. High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens.
Cheng LY; Haydu LE; Song P; Nie J; Tetzlaff MT; Kwong LN; Gershenwald JE; Davies MA; Zhang DY
Sci Rep; 2021 Apr; 11(1):9043. PubMed ID: 33907234
[TBL] [Abstract][Full Text] [Related]
35. A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma.
Richter A; Grieu F; Carrello A; Amanuel B; Namdarian K; Rynska A; Lucas A; Michael V; Bell A; Fox SB; Hewitt CA; Do H; McArthur GA; Wong SQ; Dobrovic A; Iacopetta B
Sci Rep; 2013; 3():1659. PubMed ID: 23584600
[TBL] [Abstract][Full Text] [Related]
36. Resolving Discrepancies in Idylla
George GV; Liu H; Jajosky AN; Oltvai ZN
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790156
[No Abstract] [Full Text] [Related]
37. BRAF-V600 Mutation Heterogeneity in Primary and Metastatic Melanoma: A Study With Pyrosequencing and Immunohistochemistry.
Yaman B; Kandiloğlu G; Akalin T
Am J Dermatopathol; 2016 Feb; 38(2):113-20. PubMed ID: 26630683
[TBL] [Abstract][Full Text] [Related]
38. Validation of a Manual Protocol for BRAF V600E Mutation-specific Immunohistochemistry.
Dinges HC; Capper D; Ritz O; Brüderlein S; Marienfeld R; von Deimling A; Möller P; Lennerz JK
Appl Immunohistochem Mol Morphol; 2015; 23(5):382-8. PubMed ID: 25611237
[TBL] [Abstract][Full Text] [Related]
39. Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing.
Colomba E; Hélias-Rodzewicz Z; Von Deimling A; Marin C; Terrones N; Pechaud D; Surel S; Côté JF; Peschaud F; Capper D; Blons H; Zimmermann U; Clerici T; Saiag P; Emile JF
J Mol Diagn; 2013 Jan; 15(1):94-100. PubMed ID: 23159108
[TBL] [Abstract][Full Text] [Related]
40. KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system.
Sadlecki P; Antosik P; Grzanka D; Grabiec M; Walentowicz-Sadlecka M
Tumour Biol; 2017 Oct; 39(10):1010428317733984. PubMed ID: 28992761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]